Analysis of cardiovascular status in adult relatives of 116 kindred affected with familial hyperbetalipoproteinemia (type II hyperlipoproteinemia) was carried out to assess coronary artery disease (CAD) risk in relatives with type II (II) compared to unaffected family members. Over 90% of the 738 living relatives were interviewed by one investigator and 12 lead electrocardiograms were obtained. In these, and in 285 deceased relatives, physician and hospital records were utilized to determine CAD events by standard criteria. This study, the largest of its kind, permitted more precise and extensive determination of the CAD risk accompanying severe hyperbetalipoproteinemia than has heretofore been possible. CAD was diagnosed in 29.5% of II's compared with 10.5% of normal relatives (N) (P < .001). The II's and N's did not differ significantly with regard to age distribution, sex, hypertension, smoking habits, or body mass index. According to the Rose questionnaire, angina pectoris was diagnosed in 21.8% of II's and 6.5% of N's (P < .001). Documented myocardial infarction occurred in 6% of II's versus 1% of N's (P= .002). CAD death or myocardial infarction occurred in 10.1% of II's compared with 1.8% of N's (P< .001). The cumulative probability of nonfatal or fatal CAD by age 40 in male II's was 16% (1 in 6); by age 60, the expectation of an event had risen to 52% (1 in 2). Among male N's, the risk of nonfatal or fatal CAD by age 60 was 12.7%, lagging 20 years behind that seen in male II's. In female II's, the risk of nonfatal or fatal CAD by age 60 was 32.8% compared with only 9.1% in female N's.
AT LEAST in males, the risk of premature coronary artery disease (CAD) rises directly with the serum cholesterol.1 This is particularly evident in patients with the marked elevations of cholesterol due to familial hyperbetalipoproteinemia (type II hyperlipoproteinemia), although studies of such subjects indicate considerable variation in quantitation of risk. Two studies of the more classical form of monogenic type II, familial hypercholesterolemia have demonstrated that CAD events tend to occur at an earlier age and much more frequently in affected than in unaffected family members.2 3 Other reports, however, have not shown as striking a risk of CAD events in those with hypercholesterolemia. Harlan, Graham, and Estes studied 659 individuals from one large American kindred, and found 79 affected with familial hypercholesterolemia. They noted affected relatives who survived into the seventh, and in the case of four females, into the eighth decade of life. They concluded that familial hypercholesterolemia as seen in their kindred, was a "relatively benign trait," since they found no significant differences between affected and nonaffected relatives in mean age at death or mean age of those living. 4 We have recently completed analysis of the cardiovascular status of over 1000 subjects from 116 kindred affected with familial type II hyperlipoproteinemia. The risk of CAD in hyperlipoproteinemic adults has been compared with other family members with normal levels of low density lipoproteins (LDL). Comparisons were made between both sexes and over five decades, using established techniques that will permit comparisons between this study and other studies of CAD in the general population.
Methods

Patients
The study population comprised the adults among a Circulation, Volume XLIX, Marcb 1974 total of 1403 realtives of 116 patients diagnosed during the period 1964-1970 at the National Institutes of Health Clinical Center as having familial type II hyperlipoproteinemia. This diagnosis was arbitrarily made when the patient had (1) a primary increase in low density lipoprotein cholesterol concentration (CLDL) which exceeded age-corrected upper 5% limits, and (2) either a similarly affected first degree relative or tendon xanthomas (see Appendix I). The 116 propositi were among the first 118 consecutive patients registered at the Clinical Center with familial type II hyperlipoproteinemia. Two of these 118 patients were excluded because one propositus could not be located and another was not certain that he was the father of his wife's children. About one-third of the propositi had CAD when referred; to reduce bias, they were excluded from all analyses of CAD risk. Only relatives over age 19 at the time of the survey were included in this study.
The subjects of the study fell into three major categories. In Group I were the first degree relatives of propositi. Group II comprised all first degree relatives of any member of Group I found to have type II hyperlipoproteinemia. Group III consisted of all first degree relatives of any of group II who had type II. For convenience, groups II and III are combined in the second tier of subjects shown in figure 1. In this figure are depicted the lipoprotein phenotype and numbers of all subjects available. Of the 1,023 subjects, 63 had normal CLTJL which was accompanied by a triglyceride concentration above age-corrected 5% limits. These few relatives with type IV hyperlipoproteinemia were analyzed separately and are not included in this report. Only subjects with type II hyperlipoproteinemia (II) and those who were normolipoproteinemic (N) were included. In Group I, lipoprotein phenotype was ascertained in 94% of the 380 living and in 14% of the 167 deceased subjects.
Lipid and Lipoprotein Studies
Prior to sampling, subjects were instructed to try to maintain their weight and customary diet, and to take no hypolipidemic medications for at least two weeks prior to sampling. Samples were obtained at least three months after any myocardial infarction (MI).6 After a 12-16 hr fast, 35 cc of blood was withdrawn by venipuncture, mixed in a glass tube containing EDTA (1 mg/ml) and placed on ice. The cells were removed by centrifugation and the samples kept at This was not seen in any of these samples.
XVhere quantities of plasma were insufficient to determine CLDL directly as above, CHDL, was determined and CLDI, estimated by formula: CLDL C -(CHDL + CYLOL).
CVLDL was calculated as plasma triglyceride concentration divided by five.10 If only C and triglyceride concentration were available due to small sample size or a sample being forwarded frozen, CII)T was assumed to be 45 mg% and CLDL was calculated using the above formula.10 In 44 patients for whom only a C was available, values exceeding 325 mg% were assumed to represent type II. Tendon xanthomas were present in six of the sixteen subjects with values exceeding 325 mg%.
Those with values for C below the 325 mg% cutoff were arbitrarily classified as normal. Table 1 shows the frequency with which these different analyses were employed.
Clinical Studies
One of us (NJS) administered a standardized questionnaire personally or by phone to nearly all of the living relatives (99.2% of II's and 95.7% of N's) to determine much of the clinical information. Questionnaires completed by their physicians, as well as NIH and other hospital records, were used to document the CAD end points and risk factors. Electrocardiograms (ECGs) were forwarded by 88.3% of II's and 88.6% of N's and read blinded according to pre-determined criteria.'t ECGs were selected randomly for re-reading to determine intra-observer variance. This was found to be zero for the rigid criteria employed. A magnifying lens was used to aid in the reading of the ECGs.
A close relative of every deceased subject was contacted to document whether the death occurred within or outside the hospital, was witnessed or not, and took place within two hours of the onset of acute symptoms.
Among the deceased relatives included in the study, autopsy records were obtained in six II's and two N's. Hospital records were obtained in an additional three with type II and one normal in whom no autopsies were performed. Death certificates alone were obtained in 13 Il's and three N's. In only one of the 23 deceased II's, death information was limited to a realtive's recollection; this was also the only source of death information in one of the seven deceased N's. (5) Assuiming LDL elevated if (C) greater than 325 mgc. 16 28 10 10 (5.5%) (8.5%) (5.5%/G) (6.0%) *Formula: LDL (C) = Total (C) = (HDL (C) + triglycerides/'5).
Diagnostic Criteria
Coronary artery disease was designated by any of the following: (1) angina pectoris by the Rose questionnaire;" (2) abnormal Q wave on 12 lead resting ECG as defined by the Minnesota Code item Q and QSI,1;11 (3) coronary insufficiency occurring when chest discomfort was associated with either downsloping or flat ST segments depressed at least 1.0 mm or T wave inversion or both, but not associated with an elevation of heart enzymes nor the presence of a nonischemic cause for chest discomfort; (4) myocardial infarction documented with either serum glutamic oxaloacetic transaminase or creatine phosphokinase elevated in temporal profile consistent with acute cardiac muscle necrosis or evolutionary ECG changes culminating in new Q waves or both; (5) narrowing of major coronary arteries 75% or greater as determined from hospital report of coronary angiography; and (6) CAD death denoted as occurring within two hours from the onset of acute symptoms as documented by a witness and occurring in the absence of chronic, debilitating diseases such as cancer. For individuals younger than 64 years, this last criterion has been described as yielding less than 10% false positive diagnoses.'2 Potential risk factors for CAD were measured in the following manner:
(1) Body mass index (BMI): Height and weight were determined from physician records or from phone interview. BMI was calculated in kg/M2. This measure has been shown to be least correlated with height and highly correlated with body density (inverse) and the sum of the skinfolds.'3
(2) Cigarette smoking: Several reports show that a former smoker enjoys a CAD risk similar to that of a lifelong nonsmoker.'4 15 Therefore, the nonsmoker category included both nonsmokers and former smokers of cigarettes who had stopped two or more years prior to an initial CAD event or, if no event had occurred, two or more years prior to the phone interview. The smoker category included current cigarette smokers and those former smokers who had recently quit smoking either within two years of an initial CAD event or, if no CAD event had occurred, within two years of the phone interview.
(3) High blood pressure: Elevated blood pressure (BP) was defined as systolic readings greater than 139 mm Hg or diastolic readings greater than 89 mm Hg or both as determined by a physician or by perusal of hospital records. A minimum of three abnormal readings was required to substantiate diagnosis. When the information was gleaned from the hospital record, readings taken on the first three days were ignored.
(4) ECG abnormality: This was defined as either left ventricular hypertrophy (LVH), ST segment depression, or left bundle branch block (LBBB) seen on resting 12 lead ECG. LVH was diagnosed only if it was "definite" LVH as determined by the requirement of five points by the Estes point score system.'6 ST depression required a downsloping or flat ST segment 1.0 mm depressed below baseline. LBBB was defined usiing the criteria of the New York Heart Association.'7 (5) Family history of early CAD: This was recorded as positive if a first degree relative of the patient had evidence of CAD prior to age 56.
The use of uncontrolled information sources in items (1) and (3) introduces the potential for considerable methodological error. Although data gathered in a controlled, prospective manner is preferred (as in (4) where an ECG was obtained on most relatives), these data are included here only to help demonstrate the absence of unforeseen bias in the study.
Diabetics taking insulin comprised less than 1% of II's and N's, but no uniform data on glucose intolerance among relatives was obtained.
Life In each category the denominator was the total number with information pertaining to the risk factor.
Results
Prevalence of Risk Factors
The frequencies with which certain CAD risk factors, other than hyperlipidemia, occurred among II's and N's are presented in tables 2 and 3. There was a significant difference between II's and N's only with respect to family history of CAD (P < .05). This difference did not appear when only group I relatives were similarly analyzed. The age distribution of II's and N's in group I alone or for all relatives was not significantly different ( fig. 2 ).
Prevalence of CAD Events
CAD was present in 29.6% of all II's and 10.5% of all N's (P < .001) (tables 4 and 5). Angina pectoris was detected in 21.8% of II's and 6.5% of N's interviewed (P <.001). Hard end points, either myocardial infarction or death from CAD, occurred much more frequently in II's than in N's. Prevalence of myocardial infarction was 6.0% in II's contrasted with 1.0% in N's (P< .002). Myocardial infarction or CAD death occurred in 10.1% of II's versus 1.8% of N's (P < .001). When group I relatives were separately analyzed, the difference of prevalence of CAD between II's and N's was similar. Among II's, males had a far greater frequency of CAD than females, while in the normolipoproteinemic relatives there was a greater prevalence of angina pectoris and CAD in females than in males (P < .05).
Prevalence of Abnormal Q Waves
The analysis of resting ECGs revealed no significant differences in frequency of abnormal Q waves in II's compared to N's, either in group I relatives alone or all relatives taken together.
Risk Factors and Development of CAD
Cigarette smoking proved to be a significant risk factor for a CAD event in these kindred ( times the prevalence of initial nonfatal CAD events as nonsmokers or former smokers who had stopped for more than two years before an event. Although smokers had more angina pectoris than nonsmokers, this difference was not significant (P > .05). In group I relatives alone, angina pectoris was sigificantly more frequent among smokers than nonsmokers (P < .05). Because BP, weight, and ECG data were not obtained prior to an event, similar conclusions about their relation to CAD were not justified. In group I relatives, more than 75% of II's with CAD were examined specifically for xanthomas; one third of these were examined at the Clinical Center and the remainder by their own physicians. Approximately half of those examined (44% of those with angina pectoris and 51% of those with myocardial infaretion or death from CAD) had tendon or tuberous xanthomas. sity for CAD events in male II's even prior to age 50. By age 40, the risk of fatal or nonfatal CAD events was 16.0% (19.0%)* ( fig. 3 ), compared to only 0.5% (0.9%) in male N's. From 40 to 60 years of age, the cumulative probability of a CAD event in II's rose more steeply than the cumulative probability of a CAD event in N's. By age 60, the risk for male II's was 52.0% (65.0%) compared to the risk for male N's of only 12.7% (15.6%). By age 60, expectation of CAD in male II's was, therefore, better than one in two, while in male N's it approached that seen in male II's who were younger by twenty years.
In female relatives, cumnulative probability curves were similar for II's and N's up to age 40 ( fig. 4 ). By age 50, the risk of fatal or nonfatal CAD events in women with type II was clearly different from that of their normal relatives. In II's, the risk was 19 .5% (24.9,9) compared to the ri'sk in N's of 7.6% (10.6%). By age 60, the risk in II's had reached 31.8% (36.0%); among the norrnolipoproteinemic female relatives, the risk had reached only 9.6% (14.3%).
The cumulative probability curves for myocardial inifarction or CAD death, so called`hard end points" for CAD, emphasized the early expectation of CAD events among male II's ( fig. 5 ). By age 40, the ri'sk of myocardial infarction or CAD death was 9.0% (13.0%) in male II's; no "hard" event had As with the "softer" end points, myocardial infarction or CAD death usually occurred later in the women. By age 60, the risk in female Il's was 8.3% (10.6%) and only 1.2% (2.3%) in female N's. Despite a delay in onset of serious complications of CAD enjoyed by female II's there was a sevenfold increment in CAD expectation by age 60 in affected women over relatives of their sex who did not have hyperbetalipoproteinemia.
The cumulative probability of angina pectoris in male II's had an early rise with an abrupt increase in slope after age 40 (see fig. 6 ). The risk of angina pectoris in male II's was 9.7% (7.6%) by age 40 and this rose to 43.5% (56.5%) by age 60. Although angina pectoris was infrequent in male N's prior to age 40, it occurred with increasing frequency thereafter. The risk at age 60 had reached 11.9% (13.8%).
Among females the risk of angina pectoris becomes greater in those with Type II only after age 40. By age 50, it was 21.4% (25.1%) compared with 6.9% (8.9%) in female N's. At age 60 the risk of angina pectoris in female II's had climbed to 32.8% (32.8% ) while reaching only 9.1% (12.7% ) in the normolipoproteinemic women.
Discussion
The prevalence of CAD in patients with familial hyperbetalipoproteinemia has been compared with that in their normolipidemic relatives. The propositi of the 116 kindred involved were segregated according to arbitrary criteria and the population studied may be heterogeneous with regard to genetic cause of hyperlipoproteinemia. An analysis of the lipoprotein patterns and segregation of hyperbetalipoproteinemia in children derived from a subset of this population has suggested that at least a majority of the parents have the presumed monogenic form of hyperbetalipoproteinemia known as familial hypercholesterolemia.20 2' Similar analyses Figure 3 of the adults in the present study In the hyperlipoproteinemic malo there was a marked predilection events; by age 40, the expectation ( or fatal CAD was one in five. The with increasing age; and by age 6 of either nonfatal or fatal CAD v With increasing age, hyperlipoprc eventually approached the preva pectoris seen in males, but fevw events were observed in the wome tion of CAD events showed a lag decade compared with male II's. ever, the risk of nonfatal or fatal II's in group I was about one in v RY nRAr.F
ATAL CAD
To reduce bias, the propositi were excluded from all our analyses of CAD risk. Almost one-half (54) _ of 116 propositi had CAD; of these, 49 had angina pectoris, while 26 had a history of myocardial infarction. The ten deceased propositi died at a mean age of 40.5 years. Furthermore, there were 22 deceased relatives who were excluded for lack Type U of any knowledge of their plasma lipids, but who nevertheless had affected children by a normal spouse. These relatives, who very likely had type II hyperlipoproteinemia, had died from CAD at a mean age of 46.1 years. The inclusion of these presumed type II relatives would have accentuated Normals / the CAD differences between relatives with and without type II hyperlipoproteinemia. It was noteworthy that the prevalence of CAD 40 50 6 events in normolipidemic men and women in these kindred were similar. This was in part accounted for by an unexpectedly high frequency of angina pectoris in the women (7.8%). Although the prevalence of angina pectoris in male N's of 4.9% comire in progress.
pares favorably with the results of several studies es in our Group I using the Rose questionnaire in various groups of for early CAD adult males, 22-25 similar data in adult women are of either nonfatal lacking. The reasons for this ablation of the usual risk rose steeply male preponderance of CAD events in the normo-0 the expectation lipoproteinemic relatives is not explained by the vas two in three. available information. It may be related to an ob-)teinemic women servation in the general population that angina is ilence of angina not as ominous a symptom in women as it is in men.
ver "hard" CAD
According to the Framingham study, survival in n. Their expecta-men after onset of angina pectoris was similar to of more than a that after occurrence of myocardial infarction, while Figure 6 in women below age 50, survi onset of angina pectoris was not ent from that seen in the genern tion .26 In our hands, the criterion of wave on resting ECG proved inca] differences in CAD between II's a help explain the data of Wilki Fliegelman whose study of 159 four generations of a family wit cholesterolemia included ECG's ( affected and 11 nonaffected rela "unable to demonstrate a tende mature atherosclerosis" in hyp tives. 27 On the other hand, the use of most conservative of the three criteria for an abnormal Q wave estimated the true prevalence ol normal Q waves in our kindred. 7 CAD criteria were not explicitly mentioned. Due to the small numbers of first degree relatives with CAD events (20 males and 9 females) the life table analysis was supplemented by the experience val following the of propositi who presented initially without CAD. signicantly differ-
The risk of CAD in affected males was particularly al female populastriking; by age 40 the risk of CAD was 23.7% and by age 60 the risk of CAD had risen to 85.4%. Of E an abnormal Q note, by age 60, the risk of CAD death in males pable of detecting was 54.1%. Among affected females, the risk of CAD mnd N's. This may by age 60 was 57.5%, while the risk of CAD death inson, Hand and by that age was 15.4%. Relatives with triglycerides individuals from exceeding 200 mg% were excluded, which may have *h familial hypereliminated some family members with both hypercollected from 21 lipoproteinemia and high triglycerides (type Ib ).21 itives. They were Although Harlan, Graham and Estes wrote that 2ncy toward pre-CAD at an "unusually early age was not epidemic" erlipidemic relain their kindred, the mean age of symptomatic CAD for those with hypercholesterolemia was 42 years Q and QSI,1, the in males and 50 years in females.4 Five other stud-Minnesota code ies in hypercholesterolemic subjects reviewed by probably under-these authors supported the mean age of developf significantly abment of symptomatic CAD as being about 45 years Nonetheless, the in affected males and 53 years in affected females.
.4's with abnormal
There were no suitable controls for comparisons.
revalence of 0.67%
Exercise ECG represents a more sensitive method -he 2336 Framing-for detecting CAD than was used in this study.
Guravitch employed the Master's two step test in studying members of two kindred with familial hypercholesterolemia.30 Nine of the 16 affected subjects and two of ten unaffected relatives had a positive test. The small sample size prevents a decisive evaluation. Harlan and associates found that the mean age of a positive Master's test in their asymptomatic patients with familial hypercholesterolemia was 48 years for males and 58 years for females.4 They did not, however, provide comparable data for a sample of normal relatives. All significant differences between this and past studies of cardiovascular disease in familial hypercholesterolemia can be explained by differences in design and data analysis. All are generally in agreement that CAD risk is markedly enhanced by hypercholesterolemia which is more precisely due to hyperbetalipoproteinemia. The availability of more 126  153  112  169  70  72  240  135  162  121  344  214  79  117  61  84  79  68  100  230  51   63  81  224  76  112  120   207   142  119   45   134  152  152   87  98  67  128  380  150  92  144   332   114   186   40   YES  YES  NO  YES  NO  NO  YES  YES  YES  YES  YES  YES  YES  YES  YES  YES  YES  NO  YES  YES  YES  YES  YES  NO  NO  YES  YES  YES  YES  YES  YES  YES  NO  YES  NO  YES  NO  YES  YES  NO  YES  YES  YES  YES  YES  YES  NO  NO   NO  NO  YES  NO  NO  YES  YES  YES  YES  NO  NO  NO precise criteria for CAD end points should now permit comparisons of CAD risk in those with other types of hyperlipoproteinemia. It is emphasized that the mean triglyceride concentration for the propositi in this study was 140 mg%. Studies of families with persistent elevations in both LDL and triglycerides may yield different results. Goldstein, Hazzard and Schrott have found that high cholesterol alone is less frequently seen in survivors of MI in Seattle than is an elevation of both cholesterol and triglycerides.31 well as the excellent technical help provided by Linda Kesler, B.S. In addition, we are grateful to numerous physicians at the National Heart & Lung Institute who were most helpful with their suggestions. L, = Living at end of period E = Number having an event W = Withdrawn during period P = Probability of no event in period CP = Cumulative probability of no event *CP of II's and N's significantly different P < .01.
